Leap Sale Purchase Of Stock from 2010 to 2024

LPTX Stock  USD 2.95  0.03  1.03%   
Leap Therapeutics Sale Purchase Of Stock yearly trend continues to be fairly stable with very little volatility. Sale Purchase Of Stock is likely to outpace its year average in 2024. During the period from 2010 to 2024, Leap Therapeutics Sale Purchase Of Stock regression line of annual values had r-squared of  0.13 and arithmetic mean of  15,639,137. View All Fundamentals
 
Sale Purchase Of Stock  
First Reported
2014-12-31
Previous Quarter
-210 K
Current Value
13 K
Quarterly Volatility
16.8 M
 
Yuan Drop
 
Covid
Check Leap Therapeutics financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Leap Therapeutics' main balance sheet or income statement drivers, such as Depreciation And Amortization of 336.9 K, Interest Expense of 4.8 K or Selling General Administrative of 8.7 M, as well as many indicators such as Price To Sales Ratio of 110, Dividend Yield of 0.0025 or PTB Ratio of 1.41. Leap financial statements analysis is a perfect complement when working with Leap Therapeutics Valuation or Volatility modules.
  
Check out the analysis of Leap Therapeutics Correlation against competitors.
For more information on how to buy Leap Stock please use our How to Invest in Leap Therapeutics guide.

Latest Leap Therapeutics' Sale Purchase Of Stock Growth Pattern

Below is the plot of the Sale Purchase Of Stock of Leap Therapeutics over the last few years. It is Leap Therapeutics' Sale Purchase Of Stock historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Leap Therapeutics' overall financial position and show how it may be relating to other accounts over time.
Sale Purchase Of Stock10 Years Trend
Slightly volatile
   Sale Purchase Of Stock   
       Timeline  

Leap Sale Purchase Of Stock Regression Statistics

Arithmetic Mean15,639,137
Geometric Mean0.00
Coefficient Of Variation120.98
Mean Deviation14,730,327
Median13,750,000
Standard Deviation18,920,098
Sample Variance358T
Range49.2M
R-Value(0.36)
Mean Square Error336T
R-Squared0.13
Significance0.19
Slope(1,515,827)
Total Sum of Squares5011.6T

Leap Sale Purchase Of Stock History

2024 -950.0
2023 -1000.0
2022null
2021813 K
202025.5 M
20191000 K
2018872 K

About Leap Therapeutics Financial Statements

Leap Therapeutics investors use historical fundamental indicators, such as Leap Therapeutics' Sale Purchase Of Stock, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Leap Therapeutics. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Sale Purchase Of Stock(1,000.00)(950.00)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Leap Stock Analysis

When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.